|
Real-time
Oslo Bors
14:55:33 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.600 NOK | 0.00% |
|
+1.41% | -46.98% |
Company Valuation: Elliptic Laboratories ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,882 | 2,295 | 1,786 | 1,103 | 714.9 | 454.8 | - | - |
| Change | - | -20.36% | -22.15% | -38.24% | -35.2% | -36.38% | - | - |
| Enterprise Value (EV) 1 | 2,681 | 2,129 | 1,697 | 1,046 | 671.8 | 389 | 406.2 | 411.6 |
| Change | - | -20.57% | -20.32% | -38.34% | -35.79% | -42.1% | 4.43% | 1.32% |
| P/E | -252x | -71.1x | -47.3x | 116x | -5.14x | -15.6x | -78.5x | 70.5x |
| PBR | 8.41x | 7.04x | 5.82x | 3.39x | 3.8x | 2.16x | 2.2x | 2.12x |
| PEG | - | -0x | -2.9x | -1x | 0x | 0.2x | 1x | -0x |
| Capitalization / Revenue | 45.7x | 44.1x | 26.1x | 8.36x | 6.96x | 4.57x | 3.78x | 3.03x |
| EV / Revenue | 42.5x | 40.9x | 24.8x | 7.93x | 6.54x | 3.91x | 3.38x | 2.74x |
| EV / EBITDA | -948x | -69.1x | -50.6x | 41.7x | -32.5x | -437x | 23.4x | 11.5x |
| EV / EBIT | -241x | -50.5x | -34.1x | 222x | -14.8x | -14.8x | -50.4x | 47x |
| EV / FCF | -94.3x | -59x | - | - | -29.1x | -14.4x | -36.9x | 206x |
| FCF Yield | -1.06% | -1.69% | - | - | -3.44% | -6.94% | -2.71% | 0.49% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.11 | -0.31 | -0.36 | 0.09 | -1.32 | -0.2313 | -0.0458 | 0.0511 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 63.04 | 52.06 | 68.32 | 131.9 | 102.7 | 99.54 | 120.3 | 150 |
| EBITDA 1 | -2.829 | -30.81 | -33.52 | 25.12 | -20.68 | -0.8894 | 17.36 | 35.89 |
| EBIT 1 | -11.14 | -42.13 | -49.74 | 4.71 | -45.44 | -26.28 | -8.055 | 8.765 |
| Net income 1 | -11.16 | -32.04 | -37.85 | 8.96 | -139 | -30.08 | -6.028 | 6.793 |
| Net Debt 1 | -201 | -165.5 | -89.72 | -57.04 | -43.06 | -65.79 | -48.56 | -43.2 |
| Reference price 2 | 27.750 | 22.050 | 17.040 | 10.480 | 6.790 | 3.600 | 3.600 | 3.600 |
| Nbr of stocks (in thousands) | 103,842 | 104,074 | 104,838 | 105,275 | 105,287 | 126,337 | - | - |
| Announcement Date | 10/03/22 | 17/02/23 | 15/02/24 | 27/02/25 | 26/02/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.56x | 3.91x | -437.42x | -.--% | 48.2M | |
| -2830.81x | 7.84x | 27.65x | -.--% | 33.77B | |
| 18.54x | - | - | - | 5.37B | |
| -731.16x | 0.85x | 12.55x | -.--% | 5.19B | |
| 60.6x | 1.76x | 10.5x | -.--% | 3.72B | |
| -40.15x | 4.41x | 64.51x | - | 1.41B | |
| 22.89x | - | - | - | 464M | |
| Average | -502.24x | 3.75x | -64.44x | 0% | 7.14B | |
| Weighted average by Cap. | -1,983.41x | 6.39x | 25.10x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ELABS Stock
- Valuation Elliptic Laboratories ASA
Select your edition
All financial news and data tailored to specific country editions
